Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19
계절 인간 코로나바이러스 OC43에 대한 면역은 COVID-19의 치명적인 악화를 완화합니다
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
analysed
antibody
Antibody titre
antibody titres
cleavage
cleavage site
Clinical course
Clinical data
conserved
coronavirus
coronavirus disease
Coronavirus disease 2019
Coronavirus-2
correlation
COVID-19
cross-reactive antibodies
cross-reactive antibody
cross-reactivity
detect
Deterioration
develop
disease
Effect
enzyme
enzyme-linked immunosorbent assay
epitope
Epitopes
fusion
fusion peptide
help
human coronavirus
human coronavirus OC43
Immunity
immunogenic
Immunosuppression
Inpatient
Inpatients
investigated
Mild
mitigate
not differ
OC43
Outpatient
outpatients
patients with COVID-19
peptide
peptides
Pneumonia
predict
produced
Prognosis
respiratory
S2ʹ cleavage site
SARS-CoV-2
searched
sera
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus-2
severe cases
Standard therapy
titre
with COVID-19
[DOI] 10.1016/j.ijid.2021.07.015 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ijid.2021.07.015 PMC 바로가기 [Article Type] Article